Cargando…
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
PURPOSE: Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide nove...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345811/ https://www.ncbi.nlm.nih.gov/pubmed/35723775 http://dx.doi.org/10.1007/s11102-022-01240-0 |
_version_ | 1784761514302898176 |
---|---|
author | Atila, Cihan Monnerat, Sophie Urwyler, Sandrine Andrea Refardt, Julie Winzeler, Bettina Christ-Crain, Mirjam |
author_facet | Atila, Cihan Monnerat, Sophie Urwyler, Sandrine Andrea Refardt, Julie Winzeler, Bettina Christ-Crain, Mirjam |
author_sort | Atila, Cihan |
collection | PubMed |
description | PURPOSE: Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide novel tests to assess the posterior pituitary. The exact underlying mechanism behind their stimulatory effect remains elusive. METHODS: This analysis combined data from three diagnostic studies conducted at the University Hospital Basel, Switzerland. In total, 80 healthy adults underwent the glucagon (n = 22), arginine (n = 30), or macimorelin (n = 28) stimulation tests. The primary objective was to investigate glucose course upon glucagon, arginine, and macimorelin stimulation tests and its effect on plasma copeptin release. RESULTS: Upon glucagon stimulation, the median [IQR] glucose level at baseline was 5.0 [4.6, 5.2] mmol/l, peaked at 8.1 [7.2, 9.4] mmol/l after 30 min and decreased to a minimum of 3.8 [3.5, 4.5] mmol/l after 120 min. The median copeptin increase upon glucagon stimulation was 7.7 [2.6, 28.0] pmol/l. Upon arginine, the glucose level at baseline was 4.9 [4.8, 5.5] mmol/l, peaked at 6.0 [5.2, 6.4] mmol/l after 30 min and decreased to a minimum of 4.3 [3.8, 4.8] mmol/l after 60 min. The median copeptin increase upon arginine stimulation was 4.5 [2.9, 7.5] pmol/l. Upon macimorelin, glucose levels showed no notable dynamics over the 120 min, and no major change in copeptin was observed. In the pooled dataset, a decrease in glucose levels was significantly correlated with copeptin increase (ρ = 0.53, p < 0.01). CONCLUSION: A similar course in plasma glucose was observed in the copeptin-stimulating test, i.e., after glucagon and arginine, while macimorelin had no effect on glucose and copeptin levels. We hypothesize that a drop in glucose levels observed upon glucagon and arginine might stimulate copeptin. |
format | Online Article Text |
id | pubmed-9345811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93458112022-08-04 The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study Atila, Cihan Monnerat, Sophie Urwyler, Sandrine Andrea Refardt, Julie Winzeler, Bettina Christ-Crain, Mirjam Pituitary Article PURPOSE: Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide novel tests to assess the posterior pituitary. The exact underlying mechanism behind their stimulatory effect remains elusive. METHODS: This analysis combined data from three diagnostic studies conducted at the University Hospital Basel, Switzerland. In total, 80 healthy adults underwent the glucagon (n = 22), arginine (n = 30), or macimorelin (n = 28) stimulation tests. The primary objective was to investigate glucose course upon glucagon, arginine, and macimorelin stimulation tests and its effect on plasma copeptin release. RESULTS: Upon glucagon stimulation, the median [IQR] glucose level at baseline was 5.0 [4.6, 5.2] mmol/l, peaked at 8.1 [7.2, 9.4] mmol/l after 30 min and decreased to a minimum of 3.8 [3.5, 4.5] mmol/l after 120 min. The median copeptin increase upon glucagon stimulation was 7.7 [2.6, 28.0] pmol/l. Upon arginine, the glucose level at baseline was 4.9 [4.8, 5.5] mmol/l, peaked at 6.0 [5.2, 6.4] mmol/l after 30 min and decreased to a minimum of 4.3 [3.8, 4.8] mmol/l after 60 min. The median copeptin increase upon arginine stimulation was 4.5 [2.9, 7.5] pmol/l. Upon macimorelin, glucose levels showed no notable dynamics over the 120 min, and no major change in copeptin was observed. In the pooled dataset, a decrease in glucose levels was significantly correlated with copeptin increase (ρ = 0.53, p < 0.01). CONCLUSION: A similar course in plasma glucose was observed in the copeptin-stimulating test, i.e., after glucagon and arginine, while macimorelin had no effect on glucose and copeptin levels. We hypothesize that a drop in glucose levels observed upon glucagon and arginine might stimulate copeptin. Springer US 2022-06-20 2022 /pmc/articles/PMC9345811/ /pubmed/35723775 http://dx.doi.org/10.1007/s11102-022-01240-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Atila, Cihan Monnerat, Sophie Urwyler, Sandrine Andrea Refardt, Julie Winzeler, Bettina Christ-Crain, Mirjam The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study |
title | The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study |
title_full | The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study |
title_fullStr | The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study |
title_full_unstemmed | The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study |
title_short | The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study |
title_sort | effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: data from: glucacop, macicop, and cargo study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345811/ https://www.ncbi.nlm.nih.gov/pubmed/35723775 http://dx.doi.org/10.1007/s11102-022-01240-0 |
work_keys_str_mv | AT atilacihan theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT monneratsophie theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT urwylersandrineandrea theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT refardtjulie theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT winzelerbettina theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT christcrainmirjam theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT atilacihan effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT monneratsophie effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT urwylersandrineandrea effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT refardtjulie effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT winzelerbettina effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy AT christcrainmirjam effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy |